3 to 5% of the population suffers from amblyopia, commonly known as "lazy eye". It's a vision disorder where one eye fails to develop normal vision during childhood. Vedea develops a novel child-friendly treatment for children for ages 5 to 10, leveraging this crucial developmental phase for maximum effectiveness.
An effective therapy is extremely important because amblyopia can lead to permanent reduced visual acuity if not treated early. It is crucial to prevent long-term vision impairment and associated societal impacts, ensuring optimal visual function and quality of life for affected individuals. Societal impact includes potential educational and career limitations, as well as implications for healthcare resources and economic productivity.
Company Details
- Employees
- 3
- Address
- Amsterdam, Nl
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.vedea.nl
- Keywords
- Utrecht.
- HQ
- Amsterdam
Vedea Healthware Questions
Vedea Healthware's website is http://www.vedea.nl
Vedea Healthware's LinkedIn profile is https://nl.linkedin.com/company/vedea-healthware
Vedea Healthware has
3 employees.
View email and phone details for 3
employees at Vedea Healthware.
Vedea Healthware's industry is
Hospitals and Health Care
Vedea Healthware's top competitors are
Holomoves Bv,
Neolook Solutions,
Relucent Ai,
Haskoning,
Bam Nederland,
Loop Robots,
Monobanda,
Hilversum Media Campus,
Tover,
Linksight.
Vedea Healthware's categories are Hospitals and Health Care
